Cargando…
Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders
CRISPR/Cas9 holds immense potential to treat a range of genetic disorders. Allele-specific gene disruption induced by non-homologous end-joining (NHEJ) DNA repair offers a potential treatment option for autosomal dominant disease. Here, we successfully delivered a plasmid encoding S. pyogenes Cas9 a...
Autores principales: | Christie, Kathleen A., Courtney, David G., DeDionisio, Larry A., Shern, Connie Chao, De Majumdar, Shyamasree, Mairs, Laura C., Nesbit, M. Andrew, Moore, C. B. Tara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701044/ https://www.ncbi.nlm.nih.gov/pubmed/29170458 http://dx.doi.org/10.1038/s41598-017-16279-4 |
Ejemplares similares
-
Evaluation of TGFBI corneal dystrophy and molecular diagnostic testing
por: Chao-Shern, Connie, et al.
Publicado: (2019) -
Genetic prescreening of a candidate for laser refractive surgery identifies risk for inadequate tissue response: a case report
por: Cusumano, Andrea, et al.
Publicado: (2022) -
Gene editing in the context of an increasingly complex genome
por: Blighe, K., et al.
Publicado: (2018) -
Post-LASIK exacerbation of granular corneal dystrophy type 2 in members of a chinese family
por: Chao-Shern, C, et al.
Publicado: (2018) -
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
por: Zheng, Ziwen, et al.
Publicado: (2022)